Inhalation Sciences AB raises 3.5 MSEK in new share issue ahead of IPO
STOCKHOLM, SWEDEN – May 8, 2017. Inhalation Sciences, a leading labtech company, has raised 3.5 MSEK in a private placement directed at current owners and a consortium of private Investors. The funds will be used to increase sales and development initiatives, moving the company towards its planned listing in Q.3 2017.The new share issue raised a strong interest and was significantly oversubscribed. CEO Fredrik Sjövall: “Both current and new investors have shown great interest in, and appreciation of, the development of Inhalation Sciences AB (ISAB). We achieved significant milestones in